1. Home
  2. SBEV vs CDT Comparison

SBEV vs CDT Comparison

Compare SBEV & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBEV
  • CDT
  • Stock Information
  • Founded
  • SBEV 1992
  • CDT 2019
  • Country
  • SBEV United States
  • CDT United States
  • Employees
  • SBEV N/A
  • CDT 7
  • Industry
  • SBEV Beverages (Production/Distribution)
  • CDT Biotechnology: Pharmaceutical Preparations
  • Sector
  • SBEV Consumer Staples
  • CDT Health Care
  • Exchange
  • SBEV Nasdaq
  • CDT Nasdaq
  • Market Cap
  • SBEV 11.4M
  • CDT 9.0M
  • IPO Year
  • SBEV N/A
  • CDT N/A
  • Fundamental
  • Price
  • SBEV $0.16
  • CDT $0.07
  • Analyst Decision
  • SBEV Strong Buy
  • CDT
  • Analyst Count
  • SBEV 2
  • CDT 0
  • Target Price
  • SBEV $0.75
  • CDT N/A
  • AVG Volume (30 Days)
  • SBEV 404.4K
  • CDT 16.2M
  • Earning Date
  • SBEV 11-15-2024
  • CDT 02-14-2025
  • Dividend Yield
  • SBEV N/A
  • CDT N/A
  • EPS Growth
  • SBEV N/A
  • CDT N/A
  • EPS
  • SBEV N/A
  • CDT N/A
  • Revenue
  • SBEV $6,257,725.00
  • CDT N/A
  • Revenue This Year
  • SBEV N/A
  • CDT N/A
  • Revenue Next Year
  • SBEV $182.15
  • CDT N/A
  • P/E Ratio
  • SBEV N/A
  • CDT N/A
  • Revenue Growth
  • SBEV N/A
  • CDT N/A
  • 52 Week Low
  • SBEV $0.14
  • CDT $0.06
  • 52 Week High
  • SBEV $0.73
  • CDT $5.44
  • Technical
  • Relative Strength Index (RSI)
  • SBEV 35.51
  • CDT 40.15
  • Support Level
  • SBEV $0.15
  • CDT $0.08
  • Resistance Level
  • SBEV $0.17
  • CDT $0.09
  • Average True Range (ATR)
  • SBEV 0.02
  • CDT 0.01
  • MACD
  • SBEV -0.00
  • CDT -0.00
  • Stochastic Oscillator
  • SBEV 12.91
  • CDT 27.18

About SBEV Splash Beverage Group Inc. (NV)

Splash Beverage Group Inc is a portfolio company managing multiple brands across several growth segments within the consumer beverage industry. The company's two reportable operating segments are: (1) the manufacture and distribution of non-alcoholic and alcoholic beverages, and (2) the retail sale of beverages and groceries online. The company generates the majority of its revenue from the E-Commerce segment. Qplash is a wholly owned division of Splash. It is the company's first entry point into the e-commerce channel. For beverage-alcohol products, the company operate within what is referred to as a "Three Tier Distribution System" where manufacturers are not permitted to sell directly to retailers, but instead, contract for local and regional distribution with independent distributors.

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: